4.2 Review

When does obstetric coagulopathy occur and how do I manage it?

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ijoa.2021.102979

Keywords

Hypofibrinogenaemia; Obstetric coagulopathy; Postpartum haemorrhage; Point-of-care viscoelastic haemostatic assays& nbsp; (POC-VHA)

Ask authors/readers for more resources

Early identification and treatment of coagulopathy is crucial in managing postpartum hemorrhage to improve outcomes. Viscoelastic hemostatic assays provide detailed information and guidance for treatment. Monitoring coagulation profile and response to hemostatic support are essential when these assays are not available.
Anticipating obstetric coagulopathy is important when obstetric anaesthetists are involved in the clinical management of women with postpartum haemorrhage. Although the incidence of coagulopathy in women with postpartum haemorrhage is low, significant hypofibrinogenaemia is associated with major haemorrhagerelated morbidity and thus early identification and treatment is essential to improve outcomes. Point-of-care viscoelastic haemostatic assays, including thromboelastography and rotational thromboelastometry, provide granular information about alterations in clot formation and hypofibrinogenaemia, allow near-patient interpretation of coagulopathy, and can guide goal-directed treatment. If these assays are not available, anaesthetists should closely monitor the maternal coagulation profile with standard laboratory testing during the active phase of postpartum bleeding in order to rule coagulopathy 'in or out', decide if pro-haemostatic therapies are indicated, and assess the response to haemostatic support.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available